UTMD — Utah Medical Products Cashflow Statement
0.000.00%
Last trade - 00:00- $190.55m
- $108.37m
- $40.90m
- 96
- 65
- 49
- 81
Annual cashflow statement for Utah Medical Products, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 10.8 | 14.8 | 16.5 | 16.6 | 13.9 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.202 | 0.232 | 0.272 | 0.257 | 0.324 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.99 | -1.01 | -2.23 | -0.233 | -1.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 20.1 | 21.2 | 21.1 | 22.3 | 14.8 |
| Capital Expenditures | -0.86 | -0.552 | -0.818 | -0.639 | -0.235 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | — | 0.027 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.86 | -0.552 | -0.818 | -0.639 | -0.208 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | -10.7 | -10.9 | -5.48 | -4.17 | -23.8 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 8.8 | 9.38 | 14.1 | 17.8 | -9.89 |